Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Gouérant · SciRah

Researcher profile · Semantic Scholar

S. Gouérant

Share profile

S. Gouérant — researcher profile on SciRah

h-index: 9
Works: 16
Citations: 300

Most-cited papers

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor
F. Clatot, A. Perdrix, L. Augusto, L. Beaussire +20 more
2016OncoTarget97 citations Open access
Semantic Scholar
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
F. Clatot, M. Fontanilles, L. Lefebvre, J. Lequesne +18 more
2020European Journal of Cancer38 citations Open access
Semantic Scholar
Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma.
F. Clatot, J. Picquenot, O. Choussy, S. Gouérant +6 more
2011Oral Oncology34 citations
Semantic Scholar
The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
F. Clatot, S. Gouérant, S. Mareschal, M. Cornic +8 more
2014Oral Oncology32 citations
Semantic Scholar
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial
I. Ray-Coquard, A. Savoye, C. Schiffler, M. Mouret-Reynier +20 more
2024Nature Communications26 citations Open access
Semantic Scholar
A higher body mass index and fat mass are factors predictive of docetaxel dose intensity.
S. Gouérant, M. Leheurteur, Maher Chaker, R. Modzelewski +4 more
2013Anticancer Research22 citations
Semantic Scholar
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
M. Lange, H. Laviec, H. Castel, N. Heutte +13 more
2017BMC Cancer21 citations Open access
Semantic Scholar
How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study
J. Vanbockstael, E. Coquan, S. Gouérant, D. Allouache +20 more
2016Supportive Care in Cancer14 citations
Semantic Scholar
Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma
F. Nouhaud, C. Pfister, G. Defortescu, A. Giwerc +4 more
2015Anti-Cancer Drugs13 citations
Semantic Scholar
260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)
O. Le Saux, A. Savoye, M. Mouret-reynier, C. Schiffler +16 more
2021Ovarian cancer1 citations Open access
Semantic Scholar
Randomized phase II trial evaluating the safety of peripherally inserted central catheters vs implanted port catheters during adjuvant chemotherapy in early breast cancer patients
F. Clatot, M. Fontanilles, L. Lefebvre, J. Le Quesne +16 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
M. Lange, H. Laviec, H. Castel, N. Heutte +13 more
2018BMC Cancer1 citations Open access
Semantic Scholar
[Prognostic factors for metastatic renal cell carcinoma treated with second-line targeted therapies].
J. Rebibo, C. Pfister, A. Giwerc, G. Defortescu +3 more
2016Progrès en urologie (Paris)1 citations
Semantic Scholar
1548PIS THERE A RELATIONSHIP BETWEEN PATIENT'S SATISFACTION OF THE DIAGNOSIS ANNOUNCEMENT DEVICE AND CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING?
S. Gouérant, A. Dugué, J. Vanboeckstael, D. Allouache +16 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
A higher body mass index and fat mass predict the reduction of dose-intensity for docetaxel but not for epirubicin in early breast cancer chemotherapy
S. Gouérant, M. Leheurteur, Maher Chaker, R. Modzelewski +4 more
20130 citations
Semantic Scholar
Hypoxia and Metabolism Gene Expression Profile Predicts Poor Survival in Head and Neck Carcinoma
S. Gouérant, S. Mareschal, J. Picquenot, A. Berghian +6 more
20120 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Clatot×8
Invite
F. Clatot — researcher profile on SciRah
F. Di Fiore×8
Invite
F. Di Fiore — researcher profile on SciRah
M. Leheurteur×6
Invite
M. Leheurteur — researcher profile on SciRah
O. Rigal×5
Invite
O. Rigal — researcher profile on SciRah

×5

Invite

C. Veyret — researcher profile on SciRah

Invite

C. Moldovan — researcher profile on SciRah

J. Picquenot×4

Invite

J. Picquenot — researcher profile on SciRah

Invite

E. Coquan — researcher profile on SciRah

Invite

B. Clarisse — researcher profile on SciRah

M. Bubenheim×3

Invite

M. Bubenheim — researcher profile on SciRah

C. Alexandru×3

Invite

C. Alexandru — researcher profile on SciRah

C. Guillemet×3

Invite

C. Guillemet — researcher profile on SciRah